|
XOMA Limited - Premium Company Profile (Datamonitor)
Market: Healthcare and Medical
Published Date: 24/12/2007
Market Research Report Title: XOMA Limited - Premium Company Profile
Table of Contents: View
Report Type: Company Profile
Country: Global
Number of Pages: 57
|
Enquire about Report |
Summary: Introduction
XOMA is a biopharmaceutical company focusing on the discovery and development of therapeutic antibodies for the treatment of cancer and immune diseases. The company has a broad technology platform and a fully integrated product development infrastructure for antibodies and other biologics.
Scope
Contains corporate strategy, value chain presence and SWOT AnalysisProvides detailed business description, segment analysis, 5-year financial trends, key products and key competitorsIncludes information on suppliers/ partners, shareholding structure and key employees with biographiesHighlights
XOMA′s technological platform makes the company unique from its competitors. The company′s marketed product, Lucentis was developed using its BCE technology and XOMA 052 is the first candidate being developed using another proprietary technology, Human Engineered (HE) technology.The company derives its revenues from contract, licensing, collaboration and royalties. These include upfront and milestone payments related to the outlicensing agreement with Merck & Co as well as from contracts entered with SPRI, Taligen, AVEO and NIAID, Genentech and Novartis.During 2006-2010, XOMA′s revenues are expected to grow at a CAGR of 39% rising from $29 million to $110 million, over the period 2006-2010, XOMA′s biggest contributor to sales growth out to 2010 will be from contract, license and collaboration, forecasted to grow at a CAGR of 43% from $19 million in 2006 to $81 million in 2010.Reasons to Purchase
Access all the important information and analysis on the company in a single reportUnderstand company′s strengths, weaknesses, opportunities and threats along with business strategy and value chainGain access to company′s adjusted five year financial data along with key ratios and market capitalization
Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.
www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.
